Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Long-Term Investments (2021 - 2025)

Historic Long-Term Investments for InfuSystem Holdings (INFU) over the last 5 years, with Q3 2025 value amounting to $850000.0.

  • InfuSystem Holdings' Long-Term Investments fell 2321.59% to $850000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $850000.0, marking a year-over-year decrease of 2321.59%. This contributed to the annual value of $1.5 million for FY2024, which is 270.46% up from last year.
  • Latest data reveals that InfuSystem Holdings reported Long-Term Investments of $850000.0 as of Q3 2025, which was down 2321.59% from $949000.0 recorded in Q2 2025.
  • In the past 5 years, InfuSystem Holdings' Long-Term Investments ranged from a high of $2.2 million in Q3 2023 and a low of $52000.0 during Q2 2021
  • In the last 5 years, InfuSystem Holdings' Long-Term Investments had a median value of $1.5 million in 2023 and averaged $1.3 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first soared by 45352.11% in 2022, then crashed by 4886.84% in 2024.
  • Quarter analysis of 5 years shows InfuSystem Holdings' Long-Term Investments stood at $355000.0 in 2021, then surged by 453.52% to $2.0 million in 2022, then dropped by 26.62% to $1.4 million in 2023, then increased by 2.7% to $1.5 million in 2024, then tumbled by 42.61% to $850000.0 in 2025.
  • Its Long-Term Investments was $850000.0 in Q3 2025, compared to $949000.0 in Q2 2025 and $1.2 million in Q1 2025.